Literature DB >> 25315698

Inositol 1,4,5-trisphosphate receptor type II (InsP3R-II) is reduced in obese mice, but metabolic homeostasis is preserved in mice lacking InsP3R-II.

Colleen N Feriod1, Lily Nguyen2, Michael J Jurczak3, Emma A Kruglov4, Michael H Nathanson4, Gerald I Shulman5, Anton M Bennett6, Barbara E Ehrlich7.   

Abstract

Inositol 1,4,5-trisphosphate receptor type II (InsP3R-II) is the most prevalent isoform of the InsP3R in hepatocytes and is concentrated under the canalicular membrane, where it plays an important role in bile secretion. We hypothesized that altered calcium (Ca(2+)) signaling may be involved in metabolic dysfunction, as InsP3R-mediated Ca(2+) signals have been implicated in the regulation of hepatic glucose homeostasis. Here, we find that InsP3R-II, but not InsP3R-I, is reduced in the livers of obese mice. In our investigation of the functional consequences of InsP3R-II deficiency, we found that organic anion secretion at the canalicular membrane and Ca(2+) signals were impaired. However, mice lacking InsP3R-II showed no deficits in energy balance, glucose production, glucose tolerance, or susceptibility to hepatic steatosis. Thus, our results suggest that reduced InsP3R-II expression is not sufficient to account for any disruptions in metabolic homeostasis that are observed in mouse models of obesity. We conclude that metabolic homeostasis is maintained independently of InsP3R-II. Loss of InsP3R-II does impair secretion of bile components; therefore, we suggest that conditions of obesity would lead to a decrease in this Ca(2+)-sensitive process.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  InsP3R; bile secretion; calcium; gluconeogenesis; glucose homeostasis; hepatic steatosis; insulin sensitivity

Mesh:

Substances:

Year:  2014        PMID: 25315698      PMCID: PMC4254986          DOI: 10.1152/ajpendo.00236.2014

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  43 in total

Review 1.  New perspectives into the molecular pathogenesis and treatment of type 2 diabetes.

Authors:  A R Saltiel
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants.

Authors:  Elke Vermassen; Jan B Parys; Jean-Pierre Mauger
Journal:  Biol Cell       Date:  2004-02       Impact factor: 4.458

3.  The type II inositol 1,4,5-trisphosphate receptor can trigger Ca2+ waves in rat hepatocytes.

Authors:  Keiji Hirata; Thomas Pusl; Allison F O'Neill; Jonathan A Dranoff; Michael H Nathanson
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

4.  Studies on the regulation of gluconeogenesis in isolated rat liver cells by epinephrine and glucagon.

Authors:  M E Tolbert; J N Fain
Journal:  J Biol Chem       Date:  1974-02-25       Impact factor: 5.157

5.  Early effects of 3',5'-adenosine monophosphate on the fluxes of calcium end potassium in the perfused liver of normal and adrenalectomized rats.

Authors:  N Friedmann; C R Park
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

Review 6.  Therapeutic perspectives for type 2 diabetes mellitus: molecular and clinical insights.

Authors:  F Mauvais-Jarvis; F Andreelli; H Hanaire-Broutin; B Charbonnel; J Girard
Journal:  Diabetes Metab       Date:  2001-09       Impact factor: 6.041

7.  Loss of inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis.

Authors:  Kazunori Shibao; Keiji Hirata; Marie E Robert; Michael H Nathanson
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

8.  Studies on alpha-adrenergic activation of hepatic glucose output. Studies on role of calcium in alpha-adrenergic activation of phosphorylase.

Authors:  F D Assimacopoulos-Jeannet; P F Blackmore; J H Exton
Journal:  J Biol Chem       Date:  1977-04-25       Impact factor: 5.157

9.  Distinct intracellular calcium transients in neurites and somata integrate neuronal signals.

Authors:  Friedrich W Johenning; Michal Zochowski; Stuart J Conway; Andrew B Holmes; Peter Koulen; Barbara E Ehrlich
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

10.  A novel, noninvasive method for the measurement of intestinal fat absorption.

Authors:  Ronald J Jandacek; James E Heubi; Patrick Tso
Journal:  Gastroenterology       Date:  2004-07       Impact factor: 22.682

View more
  12 in total

1.  Hepatic HAX-1 inactivation prevents metabolic diseases by enhancing mitochondrial activity and bile salt export.

Authors:  Fawzi Alogaili; Sivaprakasam Chinnarasu; Anja Jaeschke; Evangelia G Kranias; David Y Hui
Journal:  J Biol Chem       Date:  2020-02-20       Impact factor: 5.157

2.  Alcohol and calcium make a potent cocktail.

Authors:  Yasuko Iwakiri; Michael H Nathanson
Journal:  J Physiol       Date:  2017-04-18       Impact factor: 5.182

3.  Type 2 inositol trisphosphate receptor gene expression in hepatocytes is regulated by cyclic AMP.

Authors:  Emma Kruglov; Meenakshisundaram Ananthanarayanan; Pedro Sousa; Jittima Weerachayaphorn; Mateus T Guerra; Michael H Nathanson
Journal:  Biochem Biophys Res Commun       Date:  2017-03-19       Impact factor: 3.575

4.  Chronic alcohol feeding potentiates hormone-induced calcium signalling in hepatocytes.

Authors:  Paula J Bartlett; Anil Noronha Antony; Amit Agarwal; Mauricette Hilly; Victoria L Prince; Laurent Combettes; Jan B Hoek; Lawrence D Gaspers
Journal:  J Physiol       Date:  2017-04-18       Impact factor: 5.182

5.  Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis.

Authors:  Bing Zhou; Yunchen Luo; Nana Ji; Cheng Hu; Yan Lu
Journal:  Nat Metab       Date:  2022-09-01

Review 6.  Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty.

Authors:  Robert L Rodgers
Journal:  Physiol Rep       Date:  2022-05

7.  Nonalcoholic fatty liver disease impairs expression of the type II inositol 1,4,5-trisphosphate receptor.

Authors:  Tanaporn Khamphaya; Natsasi Chukijrungroat; Vitoon Saengsirisuwan; Kisha A Mitchell-Richards; Marie E Robert; Albert Mennone; Meenakshisundaram Ananthanarayanan; Michael H Nathanson; Jittima Weerachayaphorn
Journal:  Hepatology       Date:  2018-01-02       Impact factor: 17.425

8.  Molecular Mechanism for Protection Against Liver Failure in Human Yellow Fever Infection.

Authors:  Fernanda de Oliveira Lemos; Andressa França; Antônio Carlos Melo Lima Filho; Rodrigo M Florentino; Marcone Loiola Santos; Dabny G Missiaggia; Gisele Olinto Libanio Rodrigues; Felipe Ferraz Dias; Ingredy Beatriz Souza Passos; Mauro M Teixeira; Antônio Márcio de Faria Andrade; Cristiano Xavier Lima; Paula Vieira Teixeira Vidigal; Vivian Vasconcelos Costa; Matheus Castro Fonseca; Michael H Nathanson; M Fatima Leite
Journal:  Hepatol Commun       Date:  2020-03-16

9.  Hepatic Inositol 1,4,5 Trisphosphate Receptor Type 1 Mediates Fatty Liver.

Authors:  Colleen N Feriod; Andre Gustavo Oliveira; Mateus T Guerra; Lily Nguyen; Kisha Mitchell Richards; Michael J Jurczak; Hai-Bin Ruan; Joao Paulo Camporez; Xiaoyong Yang; Gerald I Shulman; Anton M Bennett; Michael H Nathanson; Barbara E Ehrlich
Journal:  Hepatol Commun       Date:  2016-11-11

10.  Calcium-dependent O-GlcNAc signaling drives liver autophagy in adaptation to starvation.

Authors:  Hai-Bin Ruan; Yina Ma; Sara Torres; Bichen Zhang; Colleen Feriod; Ryan M Heck; Kevin Qian; Minnie Fu; Xiuqi Li; Michael H Nathanson; Anton M Bennett; Yongzhan Nie; Barbara E Ehrlich; Xiaoyong Yang
Journal:  Genes Dev       Date:  2017-09-13       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.